Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Franklin › NPI 1457479552
Hospital

Wheaton Franciscan Healthcare - Franklin, INC.

Wheaton Franciscan Healthcare - Franklin, INC. was paid $436K by Medicaid between Jan 2018 and May 2018, across 88 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 13% of everything it billed.

33Billing provider infoWHEATON FRANCISCAN HEALTHCARE - FRANKLIN, INC.
FRANKLIN, WI 53132
33aNPI1457479552assigned 03/27/2007
28Total paid$436K
24GClaims15,517
24DCodes billed88
24AFirst – last monthJan 2018 – May 2018
Compared with peers

Next to other General Acute Care Hospital providers in Wisconsin

Rank by total paid#48 of 60
Median peer was paid$2.90M
This provider vs. median0.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201815,517$436K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 13% 402 359 $55K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 11% 1,149 334 $49K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 10% 924 846 $45K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 838 792 $44K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.1% 414 380 $22K
80053 Comprehensive metabolic panel 4.0% 652 605 $17K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 3.9% 690 229 $17K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3.9% 168 159 $17K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 3.6% 85 81 $16K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 186 174 $13K
87081 2.2% 207 201 $10K
45380 Colonoscopy, flexible; with biopsy, single or multiple 2.1% 69 60 $9K
76 more codes
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.1% 101 $9K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 128 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.7% 132 $7K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 935 $7K
80048 Basic metabolic panel (calcium, ionized) 1.5% 380 $7K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 87 $7K
70450 Computed tomography, head or brain; without contrast material 1.4% 142 $6K
81001 1.3% 461 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.1% 90 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.1% 230 $5K
81025 <1% 368 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 69 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 116 $4K
82962 <1% 206 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 38 $4K
71046 Radiologic examination, chest; 2 views <1% 412 $3K
97161 <1% 67 $3K
81003 <1% 277 $3K
84484 <1% 276 $2K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 15 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 52 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 52 $2K
83690 <1% 245 $2K
97162 <1% 43 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 65 $2K
82565 <1% 47 $1K
76830 Ultrasound, transvaginal <1% 16 $1K
85610 <1% 148 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 132 $915.47
84443 Thyroid stimulating hormone (TSH) <1% 55 $906.45
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 33 $883.25
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 14 $718.48
82550 <1% 60 $667.66
83605 <1% 76 $605.75
85027 <1% 81 $546.24
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 453 $501.20
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 15 $494.46
80061 Lipid panel <1% 32 $476.14
74018 <1% 26 $402.79
80076 <1% 39 $341.25
85730 <1% 52 $282.34
71045 Radiologic examination, chest; single view <1% 185 $261.82
83880 <1% 14 $238.88
85379 <1% 28 $236.40
82553 <1% 38 $190.95
87040 <1% 12 $171.52
87186 <1% 27 $167.98
83036 Hemoglobin; glycosylated (A1C) <1% 18 $162.54
86901 <1% 44 $142.28
77063 Screening digital breast tomosynthesis, bilateral <1% 17 $126.75
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 451 $120.77
73630 <1% 29 $107.55
72100 <1% 12 $83.90
86900 <1% 15 $77.23
86850 <1% 13 $64.83
73610 <1% 27 $64.80
83735 <1% 14 $64.15
73564 <1% 13 $48.80
73502 <1% 12 $32.00
96375 Therapeutic injection; each additional sequential IV push <1% 330 $28.23
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 196 $9.83
36415 Collection of venous blood by venipuncture <1% 114 $3.00
J2704 Injection, propofol, 10 mg <1% 189 $2.37
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 186 $2.17
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 336 $0.59
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 224 $0.26
J2405 Injection, ondansetron hydrochloride, per 1 mg 0% 271 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 49 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 100 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 126 $0.00
96376 0% 13 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 57 $0.00
94760 0% 170 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 71 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 17 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 49 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDICUS-JOHNSON, COREEN (PRESIDENT)